332 related articles for article (PubMed ID: 6202705)
1. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
Buss JE; Chouvet C; Gill GN
J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
[TBL] [Abstract][Full Text] [Related]
2. Role of epidermal growth factor-stimulated protein kinase in control of proliferation of A431 cells.
Gill GN; Buss JE; Lazar CS; Lifshitz A; Cooper JA
J Cell Biochem; 1982; 19(3):249-57. PubMed ID: 6296169
[TBL] [Abstract][Full Text] [Related]
3. Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor.
Lifshitz A; Lazar CS; Buss JE; Gill GN
J Cell Physiol; 1983 Jun; 115(3):235-42. PubMed ID: 6304117
[TBL] [Abstract][Full Text] [Related]
4. Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody.
Sunada H; Yu P; Peacock JS; Mendelsohn J
J Cell Physiol; 1990 Feb; 142(2):284-92. PubMed ID: 1689318
[TBL] [Abstract][Full Text] [Related]
5. Augmented desensitization to epidermal growth factor (EGF) immediate actions: a novel mechanism for altered EGF growth response in mutant A431 cells.
Karasik A; Reddy SS; Pepinsky RB; Brock T; Kahn CR
J Cell Physiol; 1990 Feb; 142(2):231-5. PubMed ID: 1689316
[TBL] [Abstract][Full Text] [Related]
6. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
Zhong H; Minneman KP
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
[TBL] [Abstract][Full Text] [Related]
7. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate.
Maa MC; Wilson LK; Moyers JS; Vines RR; Parsons JT; Parsons SJ
Oncogene; 1992 Dec; 7(12):2429-38. PubMed ID: 1281304
[TBL] [Abstract][Full Text] [Related]
9. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of epidermal growth factor-induced phosphorylation by trifluoperazine.
Ross AH; Damsky C; Phillips PD; Hwang F; Vance P
J Cell Physiol; 1985 Sep; 124(3):499-506. PubMed ID: 2413056
[TBL] [Abstract][Full Text] [Related]
11. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
[TBL] [Abstract][Full Text] [Related]
12. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R
Cancer Res; 1991 Jan; 51(1):150-6. PubMed ID: 1703031
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment.
Mermelstein FH; Abidi TF; Laskin JD
Mol Pharmacol; 1989 Dec; 36(6):848-55. PubMed ID: 2557535
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells.
Liang M; Garrison JC
Mol Pharmacol; 1992 Nov; 42(5):743-52. PubMed ID: 1435749
[TBL] [Abstract][Full Text] [Related]
15. Importance of tyrosine phosphatases in the effects of cell-cell contact and microenvironments on EGF-stimulated tyrosine phosphorylation.
Mansbridge JN; Knüchel R; Knapp AM; Sutherland RM
J Cell Physiol; 1992 Jun; 151(3):433-42. PubMed ID: 1284249
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the epidermal growth factor receptor by growth-modulating agents: effects of staurosporine, a protein kinase inhibitor.
Friedman B; Fujiki H; Rosner MR
Cancer Res; 1990 Feb; 50(3):533-8. PubMed ID: 1688732
[TBL] [Abstract][Full Text] [Related]
17. Effect of epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate on the phosphorylation of soluble acidic proteins in A431 epidermoid carcinoma cells.
Sahai A; Feuerstein N; Cooper HL; Salomon DS
Cancer Res; 1986 Aug; 46(8):4143-50. PubMed ID: 3015383
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines.
Faaland CA; Laskin JD; Thomas TJ
Cell Growth Differ; 1995 Feb; 6(2):115-21. PubMed ID: 7756170
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
Donato NJ; Rosenblum MG; Steck PA
Cell Growth Differ; 1992 May; 3(5):259-68. PubMed ID: 1378752
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the epidermal growth factor receptor by phosphorylation.
Bertics PJ; Weber W; Cochet C; Gill GN
J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
